Effective Measurement of Risperidone Treatment Outcome for Persons With Borderline Personality Disorder

Completed · Phase 4

Conditions studied: Borderline Personality Disorder

In brief

The objective of Study A is to evaluate the efficacy of risperidone on the 4 behavioral dimensions of Berderline Personality Disorder (BPD)in an open label trial:mood swings, impulsivity, thing difficulties and disturbed relationships. The secondary objective of this study (Study B)is to validate a self-report measure of clinical symptoms specific to the treatment of patients with BPD, the UAB Borderline Rating Scale(BRS).

Key facts

Study ID

NCT00204347

Run by

University of Alabama at Birmingham

People needed

20

Starts

2003-07-01

Expected to finish

2007-10-01

Last updated by the study team

2021-06-10

Who can join

Age: 19 and older. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Diagnosis of BPD

You may not qualify if…

• Any other Axis I diagnosis except dysthymia, PTSD, or generalized anxiety disorder;substance abuse within a month; unstable medical illness.

Where it is running

• University of Alabama at Birmingham — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.